Spot on debtcollecta. There have already been some FDA clarifications requested and fulfilled by MEB prior to progressing to substantive review so fingers crossed we are looking at approval sooner rather than later but agree it's weeks not days. Mental health month is good timing, but agree with other posters that Phelps could have done more in selling the product's specific attributes.
Ann: FDA Strategy and Regulatory Update, page-249
-
- There are more pages in this discussion • 444 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
